Difference between revisions of "MALE5:Volunteer Assignments and Opportunities"

From Compendium of Cancer Genome Aberrations
Jump to navigation Jump to search
VisualWikitext
[checked revision][checked revision]
(Created page with "Welcome! For assignments, please see the "Author" column below (highlighted blue). If empty (no name is present), please volunteer to create content for that disease! To vo...")
 
(4 intermediate revisions by the same user not shown)
Line 17: Line 17:
 
!'''Notes'''
 
!'''Notes'''
 
|-
 
|-
 +
|CHAPTER 2 (TUMOURS OF THE KIDNEY)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Clear_cell_renal_cell_carcinoma|Clear cell renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Multilocular_cystic_renal_neoplasm_of_low_malignant_potential|Multilocular cystic renal neoplasm of low malignant potential]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_papillary_adenoma|Renal papillary adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Papillary_renal_cell_carcinoma|Papillary renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Oncocytoma_of_the_kidney|Oncocytoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Chromophobe_renal_cell_carcinoma|Chromophobe renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Other_oncocytic_tumours_of_the_kidney|Other oncocytic tumours of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Collecting_duct_carcinoma|Collecting duct carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Clear_cell_papillary_renal_cell_tumour|Clear cell papillary renal cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mucinous_tubular_and_spindle_cell_carcinoma|Mucinous tubular and spindle cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tubulocystic_renal_cell_carcinoma|Tubulocystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Acquired_cystic_disease-associated_renal_cell_carcinoma|Acquired cystic disease-associated renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Eosinophilic_solid_and_cystic_renal_cell_carcinoma|Eosinophilic solid and cystic renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_cell_carcinoma_NOS|Renal cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:TFE3-rearranged_renal_cell_carcinomas|TFE3-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:TFEB-altered_renal_cell_carcinomas|TFEB-altered renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:ELOC_(formerly_TCEB1)-mutated_renal_cell_carcinoma|ELOC (formerly TCEB1)-mutated renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Fumarate_hydratase-deficient_renal_cell_carcinoma|Fumarate hydratase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_renal_cell_carcinoma|Succinate dehydrogenase-deficient renal cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:ALK-rearranged_renal_cell_carcinomas|ALK-rearranged renal cell carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:SMARCB1-deficient_renal_medullary_carcinoma|SMARCB1-deficient renal medullary carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_adenoma|Metanephric adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_adenofibroma|Metanephric adenofibroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metanephric_stromal_tumour|Metanephric stromal tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_kidney|Mixed epithelial and stromal tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Paediatric_cystic_nephroma|Paediatric cystic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Classic_angiomyolipoma_/_PEComa_of_the_kidney|Classic angiomyolipoma / PEComa of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Epithelioid_angiomyolipoma_/_epithelioid_PEComa_of_the_kidney|Epithelioid angiomyolipoma / epithelioid PEComa of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renal_haemangioblastoma|Renal haemangioblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Juxtaglomerular_cell_tumour|Juxtaglomerular cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Renomedullary_interstitial_cell_tumour|Renomedullary interstitial cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Ossifying_renal_tumour_of_infancy|Ossifying renal tumour of infancy]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Congenital_mesoblastic_nephroma|Congenital mesoblastic nephroma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdoid_tumour_of_the_kidney|Rhabdoid tumour of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Clear_cell_sarcoma_of_the_kidney|Clear cell sarcoma of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Nephrogenic_rests_|Nephrogenic rests]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Cystic_partially_differentiated_nephroblastoma|Cystic partially differentiated nephroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Nephroblastoma|Nephroblastoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Germ_cell_tumours_of_the_kidney|Germ cell tumours of the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 3 (TUMOURS OF THE URINARY TRACT)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Urothelial_papilloma|Urothelial papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Inverted_urothelial_papilloma|Inverted urothelial papilloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Papillary_urothelial_neoplasm_of_low_malignant_potential|Papillary urothelial neoplasm of low malignant potential]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_low-grade|Non-invasive papillary urothelial carcinoma, low-grade]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Non-invasive_papillary_urothelial_carcinoma,_high-grade|Non-invasive papillary urothelial carcinoma, high-grade]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Urothelial_carcinoma_in_situ|Urothelial carcinoma in situ]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Invasive_urothelial_carcinoma|Invasive urothelial carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Squamous_papilloma_of_the_urothelial_tract|Squamous papilloma of the urothelial tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Verrucous_carcinoma_of_the_bladder|Verrucous carcinoma of the bladder]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Pure_squamous_carcinoma_of_the_urothelial_tract|Pure squamous carcinoma of the urothelial tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Villous_adenoma|Villous adenoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Adenocarcinoma_NOS|Adenocarcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Urachal_carcinoma|Urachal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Diverticular_carcinoma|Diverticular carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Littre_gland_adenocarcinoma_of_the_urethra|Littre gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Skene_gland_adenocarcinoma_of_the_urethra|Skene gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Cowper_gland_adenocarcinoma_of_the_urethra|Cowper gland adenocarcinoma of the urethra]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Clear_cell_adenocarcinoma_of_the_urinary_tract|Clear cell adenocarcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 27: Line 684:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Endometrioid_carcinoma_of_the_urinary_tract|Endometrioid carcinoma of the urinary tract]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 36: Line 695:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 4 (TUMOURS OF THE PROSTATE)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_cystadenoma|Prostatic cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 54: Line 726:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:High-grade_prostatic_intraepithelial_neoplasia|High-grade prostatic intraepithelial neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 63: Line 737:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Intraductal_carcinoma_of_the_prostate|Intraductal carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 72: Line 748:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_acinar_adenocarcinoma|Prostatic acinar adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 81: Line 759:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_ductal_adenocarcinoma|Prostatic ductal adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 90: Line 770:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Treatment-related_neuroendocrine_prostatic_carcinoma|Treatment-related neuroendocrine prostatic carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 99: Line 781:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenosquamous_carcinoma_of_the_prostate| Adenosquamous carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 108: Line 792:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Squamous_cell_carcinoma_of_the_prostate| Squamous cell carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 117: Line 803:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenoid_cystic_(basal_cell)_carcinoma_of_the_prostate| Adenoid cystic (basal cell) carcinoma of the prostate]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 126: Line 814:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_tumour_of_uncertain_malignant_potential|Prostatic stromal tumour of uncertain malignant potential]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 135: Line 825:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Prostatic_stromal_sarcoma|Prostatic stromal sarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 144: Line 836:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Cystadenoma_of_the_seminal_vesicle|Cystadenoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 162: Line 867:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_seminal_vesicle|Adenocarcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 171: Line 878:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_cell_carcinoma_of_the_seminal_vesicle|Squamous cell carcinoma of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 180: Line 889:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_epithelial_and_stromal_tumour_of_the_seminal_vesicle|Mixed epithelial and stromal tumour of the seminal vesicle]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 189: Line 900:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 2 (TUMOURS OF THE TESTIS)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Germ_cell_neoplasia_in_situ| Germ cell neoplasia in situ]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 207: Line 931:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Specific_forms_of_intratubular_germ_cell_neoplasia| Specific forms of intratubular germ cell neoplasia]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 216: Line 942:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Gonadoblastoma| Gonadoblastoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 225: Line 953:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Seminoma| Seminoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 234: Line 964:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Embryonal_carcinoma| Embryonal carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 243: Line 975:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Yolk_sac_tumour,_postpubertal-type| Yolk sac tumour, postpubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 252: Line 986:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Choriocarcinoma| Choriocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 261: Line 997:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Placental_site_trophoblastic_tumour| Placental site trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 270: Line 1,008:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Epithelioid_trophoblastic_tumour| Epithelioid trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 279: Line 1,019:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Cystic_trophoblastic_tumour| Cystic trophoblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 288: Line 1,030:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Teratoma,_postpubertal-type|Teratoma, postpubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 297: Line 1,041:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Teratoma_with_somatic-type_malignancy|Teratoma with somatic-type malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 306: Line 1,052:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mixed_germ_cell_tumours| Mixed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 315: Line 1,063:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Regressed_germ_cell_tumours| Regressed germ cell tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 324: Line 1,074:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Spermatocytic_tumour|Spermatocytic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 333: Line 1,085:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Teratoma,_prepubertal-type| Teratoma, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 342: Line 1,096:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Yolk_sac_tumour,_prepubertal-type|Yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 351: Line 1,107:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Testicular_neuroendocrine_tumour,_prepubertal-type|Testicular neuroendocrine tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 360: Line 1,118:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_teratoma_and_yolk_sac_tumour,_prepubertal-type|Mixed teratoma and yolk sac tumour, prepubertal-type]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 369: Line 1,129:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Leydig_cell_tumour| Leydig cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 378: Line 1,140:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Sertoli_cell_tumour| Sertoli cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 387: Line 1,151:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Large_cell_calcifying_Sertoli_cell_tumour|Large cell calcifying Sertoli cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 396: Line 1,162:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adult_granulosa_cell_tumour| Adult granulosa cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 405: Line 1,173:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Juvenile_granulosa_cell_tumour| Juvenile granulosa cell tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 414: Line 1,184:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Tumours_in_the_fibroma_thecoma_group| Tumours in the fibroma thecoma group]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 423: Line 1,195:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_sex_cord_stromal_tumour|Mixed sex cord stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 432: Line 1,206:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Signet_ring_stromal_tumour|Signet ring stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 441: Line 1,217:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Myoid_gonadal_stromal_tumour|Myoid gonadal stromal tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 450: Line 1,228:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Sex_cord_stromal_tumour_NOS|Sex cord stromal tumour NOS]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 459: Line 1,239:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA)
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_cystadenoma| Serous cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 477: Line 1,270:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_tumour_of_borderline_malignancy| Serous tumour of borderline malignancy]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 486: Line 1,281:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Serous_cystadenocarcinoma| Serous cystadenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 495: Line 1,292:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_cystadenoma| Mucinous cystadenoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 504: Line 1,303:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_borderline_tumour| Mucinous borderline tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 513: Line 1,314:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mucinous_cystadenocarcinoma| Mucinous cystadenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 522: Line 1,325:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Endometrioid_tumours| Endometrioid tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 531: Line 1,336:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Clear_cell_adenocarcinoma| Clear cell adenocarcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 540: Line 1,347:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Brenner_tumour| Brenner tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 549: Line 1,358:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenoma_of_the_collecting_ducts_and_rete_testis|Adenoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 558: Line 1,369:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Adenocarcinoma_of_the_collecting_ducts_and_rete_testis|Adenocarcinoma of the collecting ducts and rete testis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 567: Line 1,380:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenomatoid_tumour| Adenomatoid tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 576: Line 1,391:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Well-differentiated_papillary_mesothelial_tumour| Well-differentiated papillary mesothelial tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 585: Line 1,402:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Mesothelioma| Mesothelioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 594: Line 1,413:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Cystadenoma_of_the_epididymis| Cystadenoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 603: Line 1,424:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Papillary_cystadenoma_of_the_epididymis| Papillary cystadenoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 612: Line 1,435:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Adenocarcinoma_of_the_epididymis| Adenocarcinoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 621: Line 1,446:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Squamous_cell_carcinoma_of_the_epididymis|Squamous cell carcinoma of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 630: Line 1,457:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:_Melanotic_neuroectodermal_tumour_of_the_epididymis| Melanotic neuroectodermal tumour of the epididymis]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 639: Line 1,468:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM)
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 +
|
 +
----
 +
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Condyloma_acuminatum|Condyloma acuminatum]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 657: Line 1,499:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Penile_intraepithelial_neoplasia,_HPV-associated|Penile intraepithelial neoplasia, HPV-associated]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Differentiated_penile_intraepithelial_neoplasia,_HPV-independent|Differentiated penile intraepithelial neoplasia, HPV-independent]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-associated_squamous_cell_carcinoma|HPV-associated squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:HPV-independent_squamous_cell_carcinoma|HPV-independent squamous cell carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Squamous_cell_carcinoma_NOS| Squamous cell carcinoma NOS]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Penile_adenosquamous_and_mucoepidermoid_carcinomas| Penile adenosquamous and mucoepidermoid carcinomas]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extramammary_Paget_disease|Extramammary Paget disease]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Basal_cell_carcinoma_of_the_scrotum|Basal cell carcinoma of the scrotum]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 9 (NEUROENDOCRINE NEOPLASMS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Well-differentiated_neuroendocrine_tumour|Well-differentiated neuroendocrine tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Small_cell_neuroendocrine_carcinoma|Small cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Large_cell_neuroendocrine_carcinoma|Large cell neuroendocrine carcinoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 666: Line 1,640:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Mixed_neuroendocrine_neoplasms|Mixed neuroendocrine neoplasms]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 675: Line 1,651:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Paraganglioma|Paraganglioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 684: Line 1,662:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|CHAPTER 10 (MESENCHYMAL TUMOURS)
 +
|
 +
----
 +
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|
 
|
 +
----
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:The_angiofibroma_family_of_tumours|The angiofibroma family of tumours]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 702: Line 1,693:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Solitary_fibrous_tumour|Solitary fibrous tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 711: Line 1,704:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Inflammatory_myofibroblastic_tumour|Inflammatory myofibroblastic tumour]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 720: Line 1,715:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Haemangioma|Haemangioma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 729: Line 1,726:
 
|
 
|
 
|-
 
|-
−
| ||Disease||
+
|[[MALE5:Angiosarcoma|Angiosarcoma]]
 +
|Disease
 +
|
 
|
 
|
 
|
 
|
Line 738: Line 1,737:
 
|
 
|
 
|-
 
|-
 +
|[[MALE5:Glomus_tumour|Glomus tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 
|
 
|
 +
|-
 +
|[[MALE5:Myointimoma|Myointimoma]]
 
|Disease
 
|Disease
 
|
 
|
Line 748: Line 1,758:
 
|
 
|
 
|
 
|
 +
|-
 +
|[[MALE5:Myopericytoma|Myopericytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_PEComa|Extrarenal PEComa]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyoma|Leiomyoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Leiomyosarcoma|Leiomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Rhabdomyosarcoma|Rhabdomyosarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Synovial_sarcoma|Synovial sarcoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Extrarenal_rhabdoid_tumour|Extrarenal rhabdoid tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Desmoplastic_small_round_cell_tumour|Desmoplastic small round cell tumour]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 11 (HAEMATOLYMPHOID TUMOURS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Extranodal_marginal_zone_lymphoma_of_MALT|Extranodal marginal zone lymphoma of MALT]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Diffuse_large_B-cell_lymphoma|Diffuse large B-cell lymphoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Plasmacytoma|Plasmacytoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:_Juvenile_xanthogranuloma| Juvenile xanthogranuloma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 12 (MELANOCYTIC LESIONS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Mucosal_melanoma|Mucosal melanoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Metastasis_to_the_urinary_tract|Metastasis to the urinary tract]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_kidney|Metastasis to the kidney]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Metastasis_to_the_testis_and_paratestis|Metastasis to the testis and paratestis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS)
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|
 +
----
 +
|-
 +
|[[MALE5:Von_Hippel-Lindau_syndrome|Von Hippel-Lindau syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[MALE5:Birt-Hogg-Dube_syndrome|Birt-Hogg-Dube syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_papillary_renal_carcinoma|Hereditary papillary renal carcinoma]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_leiomyomatosis_and_renal_cell_carcinoma_syndrome|Hereditary leiomyomatosis and renal cell carcinoma syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Succinate_dehydrogenase-deficient_tumour_syndromes|Succinate dehydrogenase-deficient tumour syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:BAP1_tumour_predisposition_syndrome|BAP1 tumour predisposition syndrome]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Hereditary_phaeochromocytoma-paraganglioma_syndromes|Hereditary phaeochromocytoma-paraganglioma syndromes]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Tuberous_sclerosis|Tuberous sclerosis]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Genitourinary_system_and_Lynch_syndrome|Genitourinary system and Lynch syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|-
 +
|[[MALE5:Hereditary_tumour_syndromes_associated_with_homologous_recombination_pathway_mutations|Hereditary tumour syndromes associated with homologous recombination pathway mutations]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Carney_complex|Carney complex]]
 +
|Disease
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|
 +
|-
 +
|[[MALE5:Peutz-Jeghers_syndrome|Peutz-Jeghers syndrome]]
 +
|Disease
 +
|[[GTS5:Volunteer Assignments and Opportunities|See GTS5 volunteer sheet for authorship  status]]
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 +
|N/A
 
|-
 
|-
 
|}
 
|}

Revision as of 16:42, 15 July 2024

Welcome!

For assignments, please see the "Author" column below (highlighted blue).

If empty (no name is present), please volunteer to create content for that disease!

To volunteer, please [Contact us] with your page of interest.

WHO Classification of Urinary and Male Genital Tumours (5th Edition) Content
Disease Page Type Author Date Assigned to Author Target Completion Date Author Content (Pending or Complete) Date Completed by Author Associate Editor Date of Last Editor Review Notes
CHAPTER 2 (TUMOURS OF THE KIDNEY)
Clear cell renal cell carcinoma Disease
Multilocular cystic renal neoplasm of low malignant potential Disease
Renal papillary adenoma Disease
Papillary renal cell carcinoma Disease
Oncocytoma of the kidney Disease
Chromophobe renal cell carcinoma Disease
Other oncocytic tumours of the kidney Disease
Collecting duct carcinoma Disease
Clear cell papillary renal cell tumour Disease
Mucinous tubular and spindle cell carcinoma Disease
Tubulocystic renal cell carcinoma Disease
Acquired cystic disease-associated renal cell carcinoma Disease
Eosinophilic solid and cystic renal cell carcinoma Disease
Renal cell carcinoma NOS Disease
TFE3-rearranged renal cell carcinomas Disease
TFEB-altered renal cell carcinomas Disease
ELOC (formerly TCEB1)-mutated renal cell carcinoma Disease
Fumarate hydratase-deficient renal cell carcinoma Disease
Succinate dehydrogenase-deficient renal cell carcinoma Disease
ALK-rearranged renal cell carcinomas Disease
SMARCB1-deficient renal medullary carcinoma Disease
Metanephric adenoma Disease
Metanephric adenofibroma Disease
Metanephric stromal tumour Disease
Mixed epithelial and stromal tumour of the kidney Disease
Paediatric cystic nephroma Disease
Classic angiomyolipoma / PEComa of the kidney Disease
Epithelioid angiomyolipoma / epithelioid PEComa of the kidney Disease
Renal haemangioblastoma Disease
Juxtaglomerular cell tumour Disease
Renomedullary interstitial cell tumour Disease
Ossifying renal tumour of infancy Disease
Congenital mesoblastic nephroma Disease
Rhabdoid tumour of the kidney Disease
Clear cell sarcoma of the kidney Disease
Nephrogenic rests Disease
Cystic partially differentiated nephroblastoma Disease
Nephroblastoma Disease
Germ cell tumours of the kidney Disease
CHAPTER 3 (TUMOURS OF THE URINARY TRACT)
Urothelial papilloma Disease
Inverted urothelial papilloma Disease
Papillary urothelial neoplasm of low malignant potential Disease
Non-invasive papillary urothelial carcinoma, low-grade Disease
Non-invasive papillary urothelial carcinoma, high-grade Disease
Urothelial carcinoma in situ Disease
Invasive urothelial carcinoma Disease
Squamous papilloma of the urothelial tract Disease
Verrucous carcinoma of the bladder Disease
Pure squamous carcinoma of the urothelial tract Disease
Villous adenoma Disease
Adenocarcinoma NOS Disease
Urachal carcinoma Disease
Diverticular carcinoma Disease
Littre gland adenocarcinoma of the urethra Disease
Skene gland adenocarcinoma of the urethra Disease
Cowper gland adenocarcinoma of the urethra Disease
Clear cell adenocarcinoma of the urinary tract Disease
Endometrioid carcinoma of the urinary tract Disease
CHAPTER 4 (TUMOURS OF THE PROSTATE)
Prostatic cystadenoma Disease
High-grade prostatic intraepithelial neoplasia Disease
Intraductal carcinoma of the prostate Disease
Prostatic acinar adenocarcinoma Disease
Prostatic ductal adenocarcinoma Disease
Treatment-related neuroendocrine prostatic carcinoma Disease
Adenosquamous carcinoma of the prostate Disease
Squamous cell carcinoma of the prostate Disease
Adenoid cystic (basal cell) carcinoma of the prostate Disease
Prostatic stromal tumour of uncertain malignant potential Disease
Prostatic stromal sarcoma Disease
CHAPTER 5 (TUMOURS OF THE SIMINAL VESICLE)
Cystadenoma of the seminal vesicle Disease
Adenocarcinoma of the seminal vesicle Disease
Squamous cell carcinoma of the seminal vesicle Disease
Mixed epithelial and stromal tumour of the seminal vesicle Disease
CHAPTER 2 (TUMOURS OF THE TESTIS)
Germ cell neoplasia in situ Disease
Specific forms of intratubular germ cell neoplasia Disease
Gonadoblastoma Disease
Seminoma Disease
Embryonal carcinoma Disease
Yolk sac tumour, postpubertal-type Disease
Choriocarcinoma Disease
Placental site trophoblastic tumour Disease
Epithelioid trophoblastic tumour Disease
Cystic trophoblastic tumour Disease
Teratoma, postpubertal-type Disease
Teratoma with somatic-type malignancy Disease
Mixed germ cell tumours Disease
Regressed germ cell tumours Disease
Spermatocytic tumour Disease
Teratoma, prepubertal-type Disease
Yolk sac tumour, prepubertal-type Disease
Testicular neuroendocrine tumour, prepubertal-type Disease
Mixed teratoma and yolk sac tumour, prepubertal-type Disease
Leydig cell tumour Disease
Sertoli cell tumour Disease
Large cell calcifying Sertoli cell tumour Disease
Adult granulosa cell tumour Disease
Juvenile granulosa cell tumour Disease
Tumours in the fibroma thecoma group Disease
Mixed sex cord stromal tumour Disease
Signet ring stromal tumour Disease
Myoid gonadal stromal tumour Disease
Sex cord stromal tumour NOS Disease
CHAPTER 7 (TUMOURS OF THE TESTICULAR ADNEXA)
Serous cystadenoma Disease
Serous tumour of borderline malignancy Disease
Serous cystadenocarcinoma Disease
Mucinous cystadenoma Disease
Mucinous borderline tumour Disease
Mucinous cystadenocarcinoma Disease
Endometrioid tumours Disease
Clear cell adenocarcinoma Disease
Brenner tumour Disease
Adenoma of the collecting ducts and rete testis Disease
Adenocarcinoma of the collecting ducts and rete testis Disease
Adenomatoid tumour Disease
Well-differentiated papillary mesothelial tumour Disease
Mesothelioma Disease
Cystadenoma of the epididymis Disease
Papillary cystadenoma of the epididymis Disease
Adenocarcinoma of the epididymis Disease
Squamous cell carcinoma of the epididymis Disease
Melanotic neuroectodermal tumour of the epididymis Disease
CHAPTER 8 (TUMOURS OF THE PENIS AND SCROTUM)
Condyloma acuminatum Disease
Penile intraepithelial neoplasia, HPV-associated Disease
Differentiated penile intraepithelial neoplasia, HPV-independent Disease
HPV-associated squamous cell carcinoma Disease
HPV-independent squamous cell carcinoma Disease
Squamous cell carcinoma NOS Disease
Penile adenosquamous and mucoepidermoid carcinomas Disease
Extramammary Paget disease Disease
Basal cell carcinoma of the scrotum Disease
CHAPTER 9 (NEUROENDOCRINE NEOPLASMS)
Well-differentiated neuroendocrine tumour Disease
Small cell neuroendocrine carcinoma Disease
Large cell neuroendocrine carcinoma Disease
Mixed neuroendocrine neoplasms Disease
Paraganglioma Disease
CHAPTER 10 (MESENCHYMAL TUMOURS)
The angiofibroma family of tumours Disease
Solitary fibrous tumour Disease
Inflammatory myofibroblastic tumour Disease
Haemangioma Disease
Angiosarcoma Disease
Glomus tumour Disease
Myointimoma Disease
Myopericytoma Disease
Extrarenal PEComa Disease
Leiomyoma Disease
Leiomyosarcoma Disease
Rhabdomyosarcoma Disease
Synovial sarcoma Disease
Extrarenal rhabdoid tumour Disease
Desmoplastic small round cell tumour Disease
CHAPTER 11 (HAEMATOLYMPHOID TUMOURS)
Extranodal marginal zone lymphoma of MALT Disease
Diffuse large B-cell lymphoma Disease
Plasmacytoma Disease
Juvenile xanthogranuloma Disease
CHAPTER 12 (MELANOCYTIC LESIONS)
Mucosal melanoma Disease
CHAPTER 13 (METASTASES IN THE GENITOURINARY SYSTEM)
Metastasis to the urinary tract Disease
Metastasis to the kidney Disease
Metastasis to the testis and paratestis Disease
CHAPTER 14 (GENETIC TUMOUR SYNDROMES OF TEH URINARY AND MALE GENITAL TRACTS)
Von Hippel-Lindau syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Birt-Hogg-Dube syndrome Disease
Hereditary papillary renal carcinoma Disease
Hereditary leiomyomatosis and renal cell carcinoma syndrome Disease
Succinate dehydrogenase-deficient tumour syndromes Disease
BAP1 tumour predisposition syndrome Disease
Hereditary phaeochromocytoma-paraganglioma syndromes Disease
Tuberous sclerosis Disease
Genitourinary system and Lynch syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Hereditary tumour syndromes associated with homologous recombination pathway mutations Disease
Carney complex Disease
Peutz-Jeghers syndrome Disease See GTS5 volunteer sheet for authorship status N/A N/A N/A N/A N/A N/A N/A
Retrieved from "https://ccga.io/index.php?title=MALE5:Volunteer_Assignments_and_Opportunities&oldid=14711"